Your browser is no longer supported. Please, upgrade your browser.
Settings
ACET Aceto Corporation daily Stock Chart
ACET [NASD]
Aceto Corporation
Index- P/E28.50 EPS (ttm)0.52 Insider Own2.30% Shs Outstand30.22M Perf Week2.66%
Market Cap443.63M Forward P/E7.73 EPS next Y1.90 Insider Trans-6.39% Shs Float29.25M Perf Month-8.48%
Income16.20M PEG2.85 EPS next Q0.47 Inst Own84.20% Short Float8.41% Perf Quarter-4.74%
Sales579.10M P/S0.77 EPS this Y2.70% Inst Trans-2.04% Short Ratio10.08 Perf Half Y-25.63%
Book/sh11.57 P/B1.27 EPS next Y37.68% ROA2.00% Target Price18.67 Perf Year-33.93%
Cash/sh2.05 P/C7.16 EPS next 5Y10.00% ROE4.60% 52W Range13.50 - 25.98 Perf YTD-33.18%
Dividend0.26 P/FCF13.16 EPS past 5Y27.90% ROI9.20% 52W High-43.49% Beta1.28
Dividend %1.77% Quick Ratio1.50 Sales past 5Y6.30% Gross Margin23.80% 52W Low8.74% ATR0.43
Employees270 Current Ratio2.10 Sales Q/Q20.40% Oper. Margin6.10% RSI (14)49.21 Volatility2.79% 2.92%
OptionableYes Debt/Eq0.91 EPS Q/Q-54.80% Profit Margin2.80% Rel Volume0.50 Prev Close14.74
ShortableYes LT Debt/Eq0.88 EarningsMay 04 AMC Payout48.80% Avg Volume243.84K Price14.68
Recom2.30 SMA200.23% SMA50-2.02% SMA200-19.38% Volume122,030 Change-0.41%
Nov-14-16Downgrade First Analysis Sec Overweight → Equal-Weight $21
Mar-31-16Initiated First Analysis Sec Overweight $30
Jul-16-15Initiated Craig Hallum Buy $30
Dec-29-14Reiterated Singular Research Buy $24 → $27
Sep-08-14Reiterated Singular Research Buy $22 → $24
May-20-14Reiterated Singular Research Buy $24 → $22
May-23-17 12:23PM  ETFs with exposure to Aceto Corp. : May 23, 2017 Capital Cube
May-22-17 10:31AM  Aceto Corp. :ACET-US: Earnings Analysis: Q3, 2017 By the Numbers : May 22, 2017 Capital Cube
May-09-17 07:40PM  Edited Transcript of ACET earnings conference call or presentation 5-May-17 1:00pm GMT Thomson Reuters StreetEvents
May-08-17 08:51AM  Aceto Corp. breached its 50 day moving average in a Bearish Manner : ACET-US : May 8, 2017 Capital Cube
May-05-17 07:30AM  Investor Network: Aceto Corporation to Host Earnings Call Accesswire -8.49%
May-04-17 07:44PM  Aceto posts 3Q profit Associated Press
05:00PM  ACETO Reports Fiscal 2017 Third Quarter Results GlobeNewswire
02:27PM  ACETO Board of Directors Declares Quarterly Cash Dividend GlobeNewswire
Apr-24-17 03:03PM  Aceto Corp. Value Analysis (NASDAQ:ACET) : April 24, 2017 Capital Cube
Apr-21-17 08:13AM  Aceto Corp. breached its 50 day moving average in a Bullish Manner : ACET-US : April 21, 2017 Capital Cube
08:00AM  ACETO Corporation Schedules Third Quarter Fiscal 2017 Financial Results News Release and Conference Call GlobeNewswire
Apr-04-17 11:45AM  Democrats found a way to speak Trump's language in pharma debate Yahoo Finance
Apr-03-17 11:38AM  Aceto Corp. : ACET-US: Dividend Analysis : March 10th, 2017 (record date) : By the numbers : April 3, 2017 Capital Cube
11:38AM  Aceto Corp. : ACET-US: Dividend Analysis : March 10th, 2017 (record date) : By the numbers : April 3, 2017
Mar-31-17 08:00AM  ACETO Subsidiary, Rising Pharmaceuticals, Launches Zileuton Extended Release Tablets, 600 mg GlobeNewswire
Mar-28-17 10:18AM  ACETO Subsidiary, Rising Pharmaceuticals, Launches Capecitabine Tablets, 150 & 500 mg GlobeNewswire
Mar-08-17 08:47AM  Should You Get Rid of INC Research (INCR) Now? Zacks
08:47AM  Should You Get Rid of INC Research (INCR) Now?
Mar-06-17 09:32AM  Top Ranked Value Stocks to Buy for March 6th Zacks
09:32AM  Top Ranked Value Stocks to Buy for March 6th
Mar-03-17 08:42AM  Should You Get Rid of Ensign Group (ENSG) Now? Zacks
08:42AM  Should You Get Rid of Ensign Group (ENSG) Now?
Mar-02-17 10:19AM  Top Ranked Value Stocks to Buy for March 2nd
Feb-28-17 10:45AM  Top Ranked Value Stocks to Buy for February 28th Zacks
10:45AM  Top Ranked Value Stocks to Buy for February 28th
Feb-27-17 09:47AM  Top Ranked Value Stocks to Buy for February 27th
Feb-24-17 09:55AM  Top Ranked Value Stocks to Buy for February 24th
Feb-22-17 10:04AM  Top Ranked Value Stocks to Buy for February 22nd
Feb-21-17 09:27AM  Top Ranked Value Stocks to Buy for February 21st
Feb-17-17 01:01PM  ACETO CORP Files SEC form 8-K/A, Financial Statements and Exhibits
Feb-16-17 09:28AM  Top Ranked Value Stocks to Buy for February 16th
Feb-15-17 09:03AM  ACETO to Present at the 2017 RBC Capital Markets Global Healthcare Conference GlobeNewswire
09:00AM  Verdezyne Launches New Corrosion Inhibitor PR Newswire
Feb-14-17 02:07PM  ETFs with exposure to Aceto Corp. : February 14, 2017
07:06AM  Top Ranked Value Stocks to Buy for February 14th
Feb-10-17 05:44AM  Aceto (ACET) is Oversold: Can It Recover?
Feb-09-17 01:04PM  ACETO CORP Financials
10:21AM  Top Ranked Value Stocks to Buy for February 9th
Feb-07-17 11:59AM  Aceto Corp. :ACET-US: Earnings Analysis: Q2, 2017 By the Numbers : February 7, 2017
10:38AM  Top Ranked Value Stocks to Buy for February 7th
Feb-06-17 07:00AM  Top Ranked Value Stocks to Buy for February 6th
Feb-03-17 03:26PM  Why Aceto Corporation's Shares Plunged 18% Today at Motley Fool -16.96%
09:00AM  Aceto Corp Earnings Call scheduled for 9:00 am ET today
07:31AM  ACETO CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
06:54AM  Top Ranked Value Stocks to Buy for February 3rd
Feb-02-17 06:14PM  Aceto reports 2Q loss
05:05PM  ACETO Reports Fiscal 2017 Second Quarter Results GlobeNewswire
03:39PM  ACETO CORP Files SEC form 8-K, Change in Directors or Principal Officers
03:06PM  ACETO Appoints Vimal Kavuru to the Board of Directors GlobeNewswire
02:05PM  ACETO Board of Directors Declares Quarterly Cash Dividend GlobeNewswire
07:07AM  Q2 2017 Aceto Corp Earnings Release - After Market Close
Jan-31-17 01:51PM  Aceto Corp. : ACET-US: Dividend Analysis : December 12th, 2016 (record date) : By the numbers : January 31, 2017
Jan-25-17 11:25AM  Top Ranked Value Stocks to Buy for January 25th
Jan-24-17 11:01AM  ACETO Corporation Schedules Second Quarter Fiscal 2017 Financial Results News Release and Conference Call GlobeNewswire
Jan-23-17 06:29AM  5 Affordable Stocks with Impressive Returns
Jan-19-17 10:07AM  Aceto Corp. Value Analysis (NASDAQ:ACET) : January 19, 2017
08:24AM  4 Stocks Flaunting Low Price-to-Cash-Flow Ratio
Jan-18-17 12:30PM  McKesson (MCK) to Pay $150 Million to Department of Justice
10:03AM  Aceto Corp. breached its 50 day moving average in a Bearish Manner : ACET-US : January 18, 2017
Jan-17-17 09:35AM  Will Aceto (ACET) Be a Suitable Pick for Value Investors?
Dec-21-16 05:08PM  ACETO CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition o
09:30AM  ACETO Completes Acquisition of Generic Products and Related Assets of Citron Pharma and Lucid Pharma GlobeNewswire
Dec-20-16 02:15PM  ACETO to Participate at Upcoming Investor Conferences in January GlobeNewswire
Dec-19-16 12:53PM  ETFs with exposure to Aceto Corp. : December 19, 2016
Dec-15-16 06:18PM  ACETO Comments on Legal Proceedings affecting the Generic Pharmaceuticals Industry GlobeNewswire
Dec-12-16 06:31PM  What Smart Money Thinks of Aceto Corporation (ACET)? at Insider Monkey
Dec-02-16 11:44AM  ETFs with exposure to Aceto Corp. : December 2, 2016
11:34AM  ACETO CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Dec-01-16 02:11PM  ACETO Board of Directors Declares Quarterly Cash Dividend GlobeNewswire
Nov-28-16 05:35PM  Edited Transcript of ACET earnings conference call or presentation 3-Nov-16 1:00pm GMT
Nov-21-16 10:56AM  Aceto Corp. :ACET-US: Earnings Analysis: Q1, 2017 By the Numbers : November 21, 2016
Nov-17-16 04:30PM  ACETO Subsidiary, Rising Pharmaceuticals, to Launch Erythromycin and Benzoyl Peroxide Topical Gel USP, 3%/5% GlobeNewswire
Nov-15-16 01:07PM  ETFs with exposure to Aceto Corp. : November 15, 2016
Nov-14-16 09:45AM  ACETO Subsidiary, Rising Pharmaceuticals, to Launch Oxybutynin Chloride Extended-Release Tablets, USP GlobeNewswire
08:06AM  Aceto Corp. breached its 50 day moving average in a Bullish Manner : ACET-US : November 14, 2016
05:59AM  Aceto downgraded by First Analysis Sec
Nov-09-16 08:25AM  New Strong Sell Stocks for November 9th +5.26%
Nov-03-16 09:00AM  Aceto Corp Earnings Call scheduled for 9:00 am ET today -10.73%
07:32AM  ACETO CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:07AM  Aceto posts 1Q profit
Nov-02-16 05:19PM  ACETO CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Ch
04:20PM  ACETO Corporation to Hold Conference Call on November 3, 2016 at 9:00 a.m. ET GlobeNewswire
04:17PM  ACETO Reports Fiscal 2017 First Quarter Results GlobeNewswire
04:15PM  ACETO to Acquire Generic Products and Related Assets of Citron Pharma and Lucid Pharma GlobeNewswire
10:19AM  Dental Stocks' Earnings Roster for Nov 3: BDX, VWR, ACET
Oct-21-16 04:05PM  ACETO Corporation Schedules First Quarter Fiscal 2017 Financial Results News Release and Conference Call GlobeNewswire
Oct-18-16 09:35AM  ETFs with exposure to Aceto Corp. : October 18, 2016
Oct-07-16 11:33AM  New Strong Sell Stocks for October 7th
Oct-05-16 10:01AM  ETFs with exposure to Aceto Corp. : October 5, 2016
08:03AM  Verdezyne Signs Distribution Agreement With Aceto Corporation PR Newswire
Oct-04-16 09:18AM  Aceto Corp. :ACET-US: Earnings Analysis: Q4, 2016 By the Numbers : October 4, 2016
Sep-27-16 11:04AM  Moving Average Crossover Alert: Aceto (ACET)
Sep-26-16 09:03AM  New Strong Sell Stocks for September 26th
Sep-16-16 09:03AM  ACETO Subsidiary, Rising Pharmaceuticals, to Launch Fluocinolone Acetonide OTIC Oil, 0.01% GlobeNewswire
Sep-09-16 09:01AM  ACETO CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Sep-07-16 11:11AM  New Strong Sell Stocks for September 7th
Sep-06-16 03:30PM  ACETO Appoints William C. Kennally, III to the Board of Directors GlobeNewswire
02:14PM  ACETO to Present at the Morgan Stanley 2016 Global Healthcare Conference GlobeNewswire
Sep-01-16 10:14AM  What Makes Aceto (ACET) a Strong Sell?
Aug-31-16 10:46AM  New Strong Sell Stocks for August 31st
Aceto Corporation, together with its subsidiaries, sources, markets, sells, and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products, and specialty chemicals. The company operates in three segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements, including vitamins, amino acids, iron compounds, and bio chemicals used in pharmaceutical and nutritional preparations. It markets and distributes its generic prescription and over the counter pharmaceutical products to wholesalers, chain drug stores, distributors, and mass market merchandisers. The Pharmaceutical Ingredients segment offers active pharmaceutical ingredients and pharmaceutical intermediates to various generic drug companies. The Performance Chemicals segment provides specialty chemicals for use in the manufacture of plastics, surface coatings, cosmetics and personal care products, textiles, and fuels and lubricants, as well as for food, flavor, paper, and film industries; dye and pigment intermediates used in the color-producing industries; and organic intermediates used in the production of agrochemicals. Its raw materials are also used in electronic parts for photo tooling, circuit boards, and production of computer chips. This segment also offers agricultural protection products comprising herbicides, fungicides, and insecticides, which control weed growth and the spread of insects and microorganisms; and sprout inhibitors for potatoes. The company serves various companies in the industrial chemical, agricultural, and human health and pharmaceutical industries primarily in the United States, Europe, and the Asia-Pacific. Aceto Corporation was founded in 1947 and is headquartered in Port Washington, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DEBENEDITTIS FRANKSr. Vice PresidentMar 09Option Exercise8.055,00040,25082,625Mar 10 09:27 AM
DEBENEDITTIS FRANKSr. Vice PresidentMar 09Sale14.943,60053,77279,025Mar 10 09:27 AM
Alaimo Charles JohnSENIOR VICE PRESIDENTMar 07Sale15.031,50022,54217,629Mar 09 03:29 PM
Yarosh Daniel B.DirectorJan 17Sale20.6989118,4358,179Jan 18 07:51 AM
Kippley TerrySr. Vice PresidentDec 09Sale21.502,00043,00020,382Dec 09 03:50 PM
Bartone RaymondSenior Vice PresidentDec 09Sale21.545,000107,70033,452Dec 09 03:46 PM
Shackley Nicolas ISENIOR VICE PRESIDENTDec 08Sale21.272,50053,16831,476Dec 08 03:35 PM
Kippley TerrySr. Vice PresidentDec 08Sale20.671,00020,67022,382Dec 09 03:50 PM
ROTH DOUGLAS ASr. Vice President & CFODec 08Sale21.035,000105,15579,478Dec 09 03:48 PM
Alaimo Charles JohnSENIOR VICE PRESIDENTDec 01Sale20.344,00081,35819,129Mar 09 03:19 PM
Kippley TerrySr. Vice PresidentNov 30Sale20.201,00020,19523,382Dec 01 03:48 PM
DEBENEDITTIS FRANKSr. Vice PresidentNov 30Sale20.201,99540,29977,625Nov 30 03:51 PM
Kippley TerrySr. Vice PresidentNov 29Sale20.491,00020,48524,382Dec 01 03:48 PM
DEBENEDITTIS FRANKSr. Vice PresidentNov 29Sale20.235,045102,08479,620Nov 30 03:51 PM
Srinivasan SatishPresident & COO - Rising PharmNov 29Sale20.0212,917258,53420,434Nov 30 03:51 PM
EILENDER ALBERT LChairmanNov 28Option Exercise7.7630,000232,800283,979Nov 28 04:10 PM
EILENDER ALBERT LChairmanNov 28Sale19.8818,500367,813265,479Nov 28 04:10 PM
Rogers StevenSVP, CHIEF LEGAL OFFICERNov 23Sale19.532,40046,87821,280Nov 23 01:04 PM
BRITTON WILLIAM NDirectorNov 14Option Exercise8.355,08142,42645,648Nov 15 11:50 AM
NOETZLI HANS CDirectorNov 14Option Exercise8.056,19949,90285,572Nov 15 11:53 AM
NOETZLI HANS CDirectorNov 14Sale18.326,000109,90679,572Nov 15 11:53 AM
BRITTON WILLIAM NDirectorNov 14Sale18.155,08192,21640,567Nov 15 11:50 AM
GUCCIONE SALVATORE J SRPRESIDENT AND CEOSep 08Sale19.642605,106198,083Sep 08 02:31 PM
ROTH DOUGLAS ASr. Vice President & CFOSep 08Sale19.741502,96184,478Sep 08 12:29 PM
Alaimo Charles JohnSENIOR VICE PRESIDENTSep 07Sale19.432548623,129Sep 08 12:27 PM
GUCCIONE SALVATORE J SRCHIEF EXECUTIVE OFFICERSep 06Sale19.8218,600368,615197,715Sep 06 04:45 PM
ROTH DOUGLAS ASr. Vice President & CFOSep 06Sale19.8610,350205,52084,317Sep 06 04:36 PM
DEBENEDITTIS FRANKSENIOR VICE PRESIDENTSep 06Sale19.854,58090,92684,665Sep 06 04:34 PM
EILENDER ALBERT LChairmanSep 06Sale19.9212,936257,645253,979Sep 06 04:33 PM
Rogers StevenSVP, CHIEF LEGAL OFFICERSep 06Sale20.042,16743,41823,680Sep 06 04:34 PM
Srinivasan SatishPresident & COO - Rising PharmSep 06Sale19.843,98078,94433,351Sep 06 04:32 PM
Shackley Nicolas ISENIOR VICE PRESIDENTSep 02Sale19.855,048100,20333,976Sep 06 01:15 PM
Kippley TerrySr. Vice PresidentSep 02Sale19.851,32126,22225,382Sep 06 01:13 PM
Bartone RaymondSENIOR VICE PRESIDENTSep 02Sale19.851,58931,54238,452Sep 06 01:13 PM
Alaimo Charles JohnSENIOR VICE PRESIDENTSep 02Sale19.852,56750,95523,092Sep 06 01:11 PM
Srinivasan SatishPresident & COO - Rising PharmJul 19Sale25.4859515,16115,521Jul 19 02:06 PM
DEBENEDITTIS FRANKSr. Vice PresidentJul 07Sale23.343,27576,42667,495Jul 07 03:22 PM
Shackley Nicolas ISr. Vice PresidentJul 06Sale22.413,56479,87020,714Jul 07 03:21 PM
Kippley TerrySr. Vice PresidentJul 06Sale22.412,14948,16017,100Jul 07 03:20 PM
Alaimo Charles JohnSENIOR VICE PRESIDENTJul 06Sale22.413,63981,55111,755Jul 07 03:17 PM
Bartone RaymondSenior Vice PresidentJul 06Sale22.412,39253,60529,717Jul 07 03:18 PM
Rogers StevenS.V.P. & CHIEF LEGAL OFFICERJul 06Sale22.503,27573,68111,943Jul 07 03:16 PM
Srinivasan SatishPresident & COO - Rising PharmJul 06Sale22.803,25074,09816,116Jul 07 03:17 PM
GUCCIONE SALVATORE J SRCHIEF EXECUTIVE OFFICERJul 06Sale23.2510,945254,420144,042Jul 07 03:14 PM
ROTH DOUGLAS ASr. Vice President & CFOJul 06Sale22.726,770153,79158,783Jul 07 03:14 PM
EILENDER ALBERT LChairmanJul 06Sale22.537,690173,219210,199Jul 07 03:13 PM
Kippley TerrySr. Vice PresidentJun 07Sale22.502,00045,00019,249Jun 09 04:20 PM
DEBENEDITTIS FRANKSr. Vice PresidentJun 06Sale22.636,810154,11070,770Jun 07 03:11 PM
Srinivasan SatishPresident & COO - Rising PharmJun 06Sale22.693,49779,34219,366Jun 07 03:12 PM
EILENDER ALBERT LChairmanMay 31Sale22.219,881219,486217,889Jun 02 03:24 PM